serialization and track-and-trace – Page 4

Data Integrity Risks in Serialization & Track-and-Trace Records

Case Study: Navigating Data Integrity Risks in Serialization and Track-and-Trace Records The pharmaceutical industry continues to face considerable challenges regarding data integrity in serialization and track-and-trace records. Non-compliance not only…

Practical SOP Controls for Serialization & Track-and-Trace

Effective Solutions for Managing Serialization and Track-and-Trace Issues In the pharmaceutical industry, proper serialization and track-and-trace systems are crucial for compliance with regulations such as the Drug Supply Chain Security…

Top Mistakes in Serialization & Track-and-Trace and How to Avoid Them

Avoiding Common Mistakes in Serialization and Track-and-Trace Processes The regulatory landscape for pharmaceutical serialization and track-and-trace systems presents significant challenges for manufacturers and distributors. Mistakes in this area can lead…

How to Build a Risk-Based Control Strategy for Serialization & Track-and-Trace

Developing a Risk-Based Control Strategy for Serialization and Track-and-Trace in Pharmaceuticals The pharmaceutical industry faces increasing challenges in ensuring compliance with serialization and track-and-trace regulations such as the DSCSA in…

Regulatory Expectations for Serialization & Track-and-Trace: What QA Must Verify

Understanding Regulatory Requirements for Serialization and Track-and-Trace in Pharmaceuticals As the pharmaceutical industry evolves, ensuring compliance with serialization track and trace requirements has become both a regulatory necessity and a…

Best Practices for Managing EU FMD alert handling issues in Serialization & Track-and-Trace

Managing EU FMD Alert Handling Issues in Serialization and Track-and-Trace: A Case Study The pharmaceutical industry has seen increased scrutiny regarding serialization and track-and-trace initiatives, particularly in light of compliance…

Audit Findings Linked to DSCSA data gaps in Serialization & Track-and-Trace

Addressing Audit Findings Related to Gaps in Serialization and Track-and-Trace Data In today’s pharmaceutical landscape, the integrity of the supply chain is paramount. Audit findings related to serialization and track-and-trace…

CAPA Strategy for aggregation failures in Serialization & Track-and-Trace

Implementing a CAPA Strategy to Address Aggregation Failures in Track-and-Trace Systems In the pharmaceutical sector, aggregation failures in serialization and track-and-trace systems are not just a nuisance; they can lead…

Root Cause Analysis for serialization reconciliation errors in Serialization & Track-and-Trace

Addressing Serialization Reconciliation Errors in Track-and-Trace Systems Serialization and track-and-trace systems are crucial in ensuring compliance with regulations like the Drug Supply Chain Security Act (DSCSA) in the U.S. and…

Inspection-Ready Checklist for Serialization & Track-and-Trace

Comprehensive Approach to Ensure Serialization and Track-and-Trace Readiness In the pharmaceutical industry, failure to comply with serialization and track-and-trace regulations can result in significant financial and operational repercussions. The implementation…

Why EU FMD alert handling issues Happens in Serialization & Track-and-Trace and How to Fix It

Understanding Handling Issues in Serialization and Track-and-Trace Systems for EU FMD Compliance The pharmaceutical industry faces ongoing challenges with serialization and track-and-trace systems, particularly when adhering to EU Falsified Medicines…

Step-by-Step Guide to DSCSA data gaps for Pharma Teams

Addressing Data Gaps in DSCSA Compliance for Pharma Teams The Drug Supply Chain Security Act (DSCSA) mandates that pharmaceutical companies implement systems for serialization and track-and-trace to enhance drug safety…